Shenzhen, China · Founded 2014 · Privately Held (backing)
Developer of anti-cancer medical solutions intended to address drug resistance and urgent clinical needs through next-generation small-molecule therapies. Tajiri is based in Shenzhen, China and was founded in 2014. Its last reported valuation was $146 million in Apr 2020. It has raised $85.8 million.
Last reported valuation
$145.6M
Oct 2026
Priced at
—
Total raised
$85.8M
Last round
—
Team — not yet on record
No current team members for Tajiri are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Tajiri with a free account
·The complete investor list: 12 names
·Watch Tajiri: the Monday email on marks, rounds and moves
